Procept Biorobotics
PRCT
96 hedge funds and large institutions have $1.14B invested in Procept Biorobotics in 2022 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 5 closing their positions.
780% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 5
154% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 13
66% more funds holding
Funds holding: 58 → 96 (+38)
8.51% more ownership
Funds ownership: 70.42% → 78.93% (+8.5%)
5% more capital invested
Capital invested by funds: $1.08B → $1.14B (+$55.9M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
44% less call options, than puts
Call options by funds: $2.72M | Put options by funds: $4.87M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$67.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$37.5M |
| 3 |
BlackRock
New York
|
+$33.1M |
| 4 |
FRA
Frank Rimerman Advisors
Palo Alto,
California
|
+$29.5M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$21.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$76.9M |
| 2 |
DFO
Duquesne Family Office
New York
|
-$39.6M |
| 3 |
PA
Perceptive Advisors
New York
|
-$26.9M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$17.6M |
| 5 |
DI
DUMAC Inc
Durham,
North Carolina
|
-$5.78M |
PRCT Hedge Fund Activity: Q2 2022 in Review
96 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q2 2022, worth a combined $1.14B — up 5.2% from $1.08B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new PRCT positions and 5 closed out — a net gain of 39 holders — while 33 added to existing stakes and 13 trimmed.
The largest buyer was Vanguard Group, adding an estimated $67.2M. The largest seller was Viking Global Investors, cutting an estimated $76.9M.
- 96 institutional investors held Procept Biorobotics (PRCT) as of Q2 2022, up from 58 in Q1 2022.
- Funds reported $1.14B of Procept Biorobotics stock for Q2 2022, up 5.2% quarter-over-quarter.
- 44 funds opened new Procept Biorobotics positions in Q2 2022 and 5 closed out, a net change of +39 holders.
- The largest Procept Biorobotics buyer in Q2 2022 was Vanguard Group, an estimated $67.2M added.
- The largest Procept Biorobotics seller in Q2 2022 was Viking Global Investors, an estimated $76.9M sold.
Based on aggregated 13F filings for Q2 2022.